Literature DB >> 1360770

Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium.

A Ullman1, A Bergendal, A Lindén, B Waldeck, B E Skoogh, C G Löfdahl.   

Abstract

Formoterol and salmeterol are 2 newly developed beta 2-adrenoceptor agonists for inhalation with prolonged duration of effect compared with currently available beta 2-agonists. The clinical duration of effect has been suggested to be correlated to a decreased washability in vitro, i.e. decreased effect due to continuous washing of the organ bath. In this study we compared the washability and the onset of the relaxatory effect of formoterol (0.01 microM), salmeterol (0.05 microM) and salbutamol (0.1 microM) in isolated guinea pig trachea contracted with carbachol (0.1 microM). We also evaluated a possible influence of the epithelium on onset of action and/or duration of effect. A significant relaxatory effect of formoterol and salmeterol remained after washing, whereas no effect of salbutamol remained. We also found a rapid onset of action for both salbutamol and formoterol, but a significantly slower onset for salmeterol. Both the washability and the onset of action were found to be independent of the presence of the epithelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360770     DOI: 10.1111/j.1398-9995.1992.tb02076.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

Review 1.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 2.  Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

Authors:  A Lindén; K F Rabe; C G Löfdahl
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.

Authors:  A Bergendal; A Lindén; B E Skoogh; M Gerspacher; G P Anderson; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Effects of RP 73401, a novel, potent and selective phosphodiesterase type 4 inhibitor, on contractility of human, isolated bronchial muscle.

Authors:  E Naline; Y Qian; C Advenier; D Raeburn; J A Karlsson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.

Authors:  A Lindén; A Bergendal; A Ullman; B E Skoogh; C G Löfdahl
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

6.  Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.

Authors:  P Anderson; J Lötvall; A Lindén
Journal:  Lung       Date:  1996       Impact factor: 2.584

7.  Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle.

Authors:  K E Ellis; R Mistry; J P Boyle; R A Challiss
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.

Authors:  A Bergendal; A Lindén; J Lötvall; B E Skoogh; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.